文献
J-GLOBAL ID:201802250862671642
整理番号:18A0467812
びまん性大細胞型B細胞リンパ腫と心臓併存疾患を持つ患者における非ペグ化リポソームドキソルビシン併用療法Fondazione ItalianaによるHEART01第II相試験の結果Linfomi【Powered by NICT】
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi
著者 (22件):
Luminari Stefano
(Hematology, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy)
,
Luminari Stefano
(Department of Diagnostic, Clinic and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy)
,
Viel Elda
(Cardiology Unit, National Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Pordenone, Italy)
,
Ferreri Andres Jose Maria
(Unit of Lymphoid Malignancies, IRCCS San Raffaele Scientific Institute, Milan, Italy)
,
Zaja Francesco
(Haematology Section, DISM, Azienda Sanitaria Universitaria Integrata S. M. Misericordia, Udine, Italy)
,
Chimienti Emanuela
(Division of Medical Oncology A, National Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Pordenone, Italy)
,
Musuraca Gerardo
(Department of Hematology, Istituto Scientifico Romagnolo per Studio e Cura dei Tumori, Meldola, Forli-Cesena, Italy)
,
Tucci Alessandra
(Division of Hematology, Spedali Civili, Brescia, Italy)
,
Balzarotti Monica
(Hematology Unit, Humanitas Cancer Center, Rozzano, Milan, Italy)
,
Tani Monica
(Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy)
,
Salvi Francesca
(Department of Hematology, SS Antonio E Biagio E Cesare Arrigo Hospital, Alessandria, Italy)
,
Pesce Emanuela A.
(Fondazione Italiana Linfomi Onlus, Italy)
,
Ferrari Angela
(Hematology, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy)
,
Liberati Anna M.
(Oncohematology, AO S. Maria di Terni, Terni, Italy)
,
Spadea Antonio
(Hematology and Stem Cell Transplant Unit, Regina Elena National Cancer Institute, Rome, Italy)
,
Marino Dario
(Division of Medical Oncology 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy)
,
Bruno-Ventre Maria
(Unit of Lymphoid Malignancies, IRCCS San Raffaele Scientific Institute, Milan, Italy)
,
Volpetti Stefano
(Haematology Section, DISM, Azienda Sanitaria Universitaria Integrata S. M. Misericordia, Udine, Italy)
,
Bottelli Chiara
(Division of Hematology, Spedali Civili, Brescia, Italy)
,
Ravaioli Elena
(Division of Medical Oncology A, National Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Pordenone, Italy)
,
Merli Francesco
(Hematology, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy)
,
Spina Michele
(Division of Medical Oncology A, National Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Pordenone, Italy)
資料名:
Hematological Oncology
(Hematological Oncology)
巻:
36
号:
1
ページ:
68-75
発行年:
2018年
JST資料番号:
D0357E
ISSN:
0278-0232
CODEN:
HAONDL
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)